High-Dose Intramuscular Triamcinolone in Severe, Chronic, Life-Threatening Asthma
Authors:
- Thomas K. AldrichTAThomas K. Aldrich
- David J. PrezantDPDavid J. Prezant
- Mark J. SinnettMSMark J. Sinnett
- Jay B. EndenJEJay B. Enden
- M. Henry Jr. WilliamsMWM. Henry Jr. Williams
Open Access
- 28 February 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (9) , 585-589
Abstract
Despite oral corticosteroid therapy, some patients with asthma have frequent exacerbations requiring emergency room visits, hospitalization, and occasionally, mechanical ventilation. We compared the effects of high-dose intramuscular triamcinolone with oral prednisone in patients with severe chronic asthma.Keywords
This publication has 14 references indexed in Scilit:
- FRIDAY, NOVEMBER 3Chest, 1989
- Increasing Severity of Asthma from 1960 to 1987New England Journal of Medicine, 1989
- Methotrexate in the Treatment of Corticosteroid-Dependent AsthmaNew England Journal of Medicine, 1988
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Chrysotherapy in the treatment of corticosteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1987
- An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthmaJournal of Allergy and Clinical Immunology, 1986
- Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma.Thorax, 1984
- Life-threatening asthmaArchives of internal medicine (1960), 1980
- Triamcinolone in corticosteroid-resistant asthmaRespiratory Medicine, 1979
- Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitisJournal of Allergy and Clinical Immunology, 1974